{ "tag": [ "compiled" ], "id": "ocds-h6vhtk-067e3d-2026-04-08T15:21:24+01:00", "date": "2026-04-08T15:21:24+01:00", "ocid": "ocds-h6vhtk-067e3d", "initiationType": "tender", "parties": [ { "id": "GB-PPON-PVVQ-6113-CJWD", "name": "Healthcare Quality Improvement Partnership Ltd", "identifier": { "scheme": "GB-PPON", "id": "PVVQ-6113-CJWD" }, "address": { "streetAddress": "128 City Road", "locality": "London", "postalCode": "EC1V 2NX", "country": "GB", "countryName": "United Kingdom", "region": "UKI43" }, "contactPoint": { "email": "procurement@hqip.org.uk", "telephone": "0000000000" }, "roles": [ "buyer" ], "details": { "classifications": [ { "id": "publicAuthoritySubCentralGovernment", "scheme": "UK_CA_TYPE", "description": "Public authority - sub-central government" } ] } } ], "buyer": { "id": "GB-PPON-PVVQ-6113-CJWD", "name": "Healthcare Quality Improvement Partnership Ltd" }, "tender": { "id": "HQIP NCA 996819026", "legalBasis": { "id": "2023/54", "scheme": "UKPGA", "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents" }, "title": "National Paediatric Critical Care Audit", "description": "The contract will initially be delivered for NHS-funded care in England for a period of 3 years, at a maximum total budget of up to PS2,832,765.70 GBP including VAT, PS2,360,638.08 GBP excluding VAT. Bids exceeding this limit will be rejected. There is potential to extend the contract for up to two additional years at a potential value of PS944,256 per year including VAT, PS786,880 per year excluding VAT. All pricing submissions must be in regard to this 'core' value, and not inclusive of any extension costs or aspirational intent costs, i.e. Please only submit a cost schedule up to the maximum core value of PS2,832,765.70 GBP including VAT, PS2,360,638.08 GBP excluding VAT. The maximum budget 'core' value is PS2,832,765.70 GBP including VAT, PS2,360,638.08 GBP excluding VAT excludes the potential two year extension and aspirational intent as described in section 14 of Annex A - Service Specification. Please note, there is no commitment by the Authority at this stage to include any aspirational intent measures. Taking the total of this aspirational intent into account, as well as the possibility that a contract extension may be offered for an additional two years, the potential ceiling value is PS11,874,282 GBP including VAT. There is also a potential that the contract price will be subject to discretionary inflationary uplift. The role of a national clinical audit is to stimulate healthcare quality improvement through the provision of high-quality information on the organisation, delivery and outcomes of healthcare, together with tools and support to enable healthcare providers and other audiences to make best use of this information. Outcomes are benchmarked against available national guidance and standards e.g. quality standards from the National Institute for Health and Care Excellence (NICE), and those from other established professional and patient sources. Successful national audits are those where the individuals who are engaging with and using the audit results are also in a position to improve the system, and where there is a shared understanding of what good care looks like. National clinical audits are expected to: a.Develop a robust, high-quality audit designed around key quality metrics likely to best support local and national healthcare quality improvement b.Detect, describe and help reduce unwarranted clinical variation by systematically benchmarking performance, identifying outliers, and supporting services to understand variation in outcomes, processes and experience c.Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate d.Enable healthcare quality improvement through the provision of timely, high-quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health board, Integrated Care System (ICS), commissioner, multidisciplinary team (MDT), possibly consultant or clinical team level and other levels of reporting e.Engage patients, carers and the public in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit f.Consider the value and feasibility of linking data at an individual patient level to other relevant national datasets either from the outset or in the future, and plan for these linkages from the inception of the contract g.Ensure robust methodological and statistical input at all stages of the audit h.Identify from the outset the full range of audiences for the reports and other audit outputs, and plan and tailor them accordingly i.Provide audit results in a timely, accessible and meaningful manner to support healthcare quality improvement, minimising the reporting delay and providing continual access to each unit for their own data j.Utilise strong and effective project and programme management to deliver audit outputs on time and within budget k.Develop and maintain strong engagement with local clinicians, networks, commissioners, patients and their families and carers and charity and community support groups to drive improvements in services At the time of writing the specification, requirements include (but please also refer to the potential future aspirational intent section of Annex A - Service Specification): *A continuation of key existing elements of the NPCCA together with an expansion of workstreams to cover additional services and aspects of care delivery *Continued collection and reporting of information on care delivery in Level 3 PCC services and PCC transport services (continuous audit). As a guide, this will need to be broadly aligned with the current delivery and include ongoing provision of data to NHS England for commissioning purposes *Expansion of services covered, to include Level 2 PCC services and ECMO services (continuous audit). As a guide, this will need to be broadly aligned with the current delivery for Level 3 PCC services *Development and delivery of quality methods for capturing the experiences of patients and carers, including the provision of psychological support (this is to be developed by the supplier during the first year, with approval by HQIP and funder). As a guide, the methods might include but are not limited to: patient/carer surveys; organisational audit questions covering aspects of patient/carer experience; and clinical audit questions about whether delivery of care included carers as partners. The development should include co-production with carer and patient representatives (such as charities and family support groups). The supplier will be expected to investigate previously established methods of capturing carer experience as part of the development. As the development will happen during the contract, the tender response does not need to contain specifics, but bidders should provide a broad outline of their ambitions for this aspect (e.g. an expectation to deliver one or multiple methods; frequency of delivery (for each method); scale of delivery (for each method)) *Development and delivery of methods for capturing aspects of service organisation, to include staffing (this is to be developed by the supplier during the first year, either combined with or separate from the development of methods for capturing experience, with approval by HQIP and funder). As a guide, the methods might include but are not limited to: staffing survey(s); organisational I[audit(s). If an organisational audit is chosen, this can be used to cover patient and carer experience too, if deemed appropriate. There have been previous staffing surveys, either as part of the NPCCA or separately funded, and consideration should be given to whether the collection of the same dataset would prove useful and efficient. The minimum requirement is for one method to be delivered once in the three-year contract. Bidders should provide an outline of their ambitions for this aspect (e.g. an expectation to deliver one or multiple methods; frequency of delivery (for each method); scale of delivery (for each method)) *A thematic focus (one during the three-year contract) on a particular aspect of care delivery, chosen from the following topics: oadolescent access; otransport refusals; otransition to tertiary specialists; otransitions from Neonatal Intensive Care Unit (NICU) to PICU (including delays); otransitions from PICU to Adult Intensive Care Unit (AICU); ovariation in length of stay; oventilator weaning practices; odischarge delays; olong-term ventilation (LTV) pathway; ovaccine preventable disease This is to be developed by the supplier during the first year, with approval by HQIP and funder. Bidders should give information on how they will approach choosing the focus area *Where relevant, data linkage with other programmes (including within NCAPOP) may be required", "status": "active", "items": [ { "id": "1", "additionalClassifications": [ { "scheme": "CPV", "id": "85100000", "description": "Health services" } ], "deliveryAddresses": [ { "region": "UK", "country": "GB", "countryName": "United Kingdom" } ], "relatedLot": "1" } ], "value": { "amountGross": 11874282, "amount": 9499425.6, "currency": "GBP" }, "procurementMethod": "open", "procurementMethodDetails": "Open procedure", "mainProcurementCategory": "services", "aboveThreshold": true, "submissionMethodDetails": "https://www.delta-esourcing.com/respond/555BG3NZH4", "submissionTerms": { "electronicSubmissionPolicy": "allowed", "languages": [ "en" ] }, "tenderPeriod": { "endDate": "2026-05-08T12:00:00+01:00" }, "enquiryPeriod": { "endDate": "2026-04-24T12:00:00+01:00" }, "awardPeriod": { "endDate": "2026-10-01T23:59:59+01:00" }, "lots": [ { "id": "1", "status": "active", "value": { "amountGross": 11874282, "amount": 9499425.6, "currency": "GBP" }, "awardCriteria": { "criteria": [ { "type": "quality", "name": "LEADERSHIP", "description": "500 word count", "numbers": [ { "number": 4, "weight": "percentageExact" } ] }, { "type": "quality", "name": "ENGAGING AND INVOLVING PATIENTS, CARERS AND THE PUBLIC", "description": "500 word count", "numbers": [ { "number": 8, "weight": "percentageExact" } ] }, { "type": "quality", "name": "STIMULATING HEALTHCARE QUALITY IMPROVEMENT", "description": "750 word count", "numbers": [ { "number": 12, "weight": "percentageExact" } ] }, { "type": "quality", "name": "HEALTHCARE PROVIDER ENGAGEMENT, PARTICIPATION AND SUPPORT", "description": "500 word count", "numbers": [ { "number": 5, "weight": "percentageExact" } ] }, { "type": "quality", "name": "DATA ACQUISITION STRATEGY AND BURDEN", "description": "750 word count", "numbers": [ { "number": 12, "weight": "percentageExact" } ] }, { "type": "quality", "name": "INFORMATION GOVERNANCE", "description": "250 word count", "numbers": [ { "number": 4, "weight": "percentageExact" } ] }, { "type": "quality", "name": "DATA QUALITY ANALYSIS", "description": "750 word count", "numbers": [ { "number": 12, "weight": "percentageExact" } ] }, { "type": "quality", "name": "USES OF THE DATA", "description": "750 word count", "numbers": [ { "number": 12, "weight": "percentageExact" } ] }, { "type": "quality", "name": "PROGRAMME GOVERNANCE AND DELIVERY PLAN", "description": "750 word count", "numbers": [ { "number": 12, "weight": "percentageExact" } ] }, { "type": "quality", "name": "RISK MANAGEMENT", "description": "250 word count", "numbers": [ { "number": 4, "weight": "percentageExact" } ] }, { "type": "cost", "name": "COST AND ALLOCATION OF BUDGET", "description": "250 word count", "numbers": [ { "number": 5, "weight": "percentageExact" } ] }, { "type": "quality", "name": "SOCIAL VALUE", "description": "500 word count", "numbers": [ { "number": 10, "weight": "percentageExact" } ] } ] }, "suitability": { "sme": true, "vcse": true }, "contractPeriod": { "startDate": "2027-04-01T00:00:00+01:00", "endDate": "2030-03-31T23:59:59+00:00", "maxExtentDate": "2032-03-31T23:59:59+01:00" }, "hasRenewal": true, "renewal": { "description": "Up to 24 month extension at a potential value of PS944,256 per year including VAT, PS786,880 per year excluding VAT. This proposed extension value will also include pro rata funding of any additional aspirational measures invoked in the first 3 years of the contract. For example: If an aspirational annual requirement costing PS500,000 per year is invoked in year 3, then the extension funding (if the aspirational measure is continued) will be the above figures plus the additional PS500,000 per year." } } ], "documents": [ { "id": "conflictOfInterest", "documentType": "conflictOfInterest", "description": "Not published" }, { "id": "A-14461", "documentType": "biddingDocuments", "url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-14461", "format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document" }, { "id": "A-14462", "documentType": "biddingDocuments", "url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-14462", "format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document" }, { "id": "032045-2026", "documentType": "tenderNotice", "noticeType": "UK4", "description": "Tender notice on Find a Tender", "url": "https://www.find-tender.service.gov.uk/Notice/032045-2026", "datePublished": "2026-04-08T15:21:24+01:00", "format": "text/html" } ], "contractTerms": { "financialTerms": "Payment will be made quarterly in arrears as described in the provider terms (Annex B). Disputed invoices will be dealt with as described in the provider terms (Annex B)" }, "riskDetails": "Full descriptive details of these measures, as well as the mechanisms for invoking them can be found in section 13.4 of Annex A - Service Specification. All figures are inclusive of VAT 1. Up to 24-month extension that mirrors the NCAPOP headline contract (Please refer to Annex J - NHSE_HQIP NCAPOP Contract REDACTED) - Up to PS1,888,510 plus a pro-rata of any costs invoked under aspirational intent 2. Inclusion of additional clinical audits and/or clinical Outcome Review Programmes (CORP) - Up to PS1,440,000 3. Transition to different models of data collection/outputs &/or operational methods/processes for the audit. This may include implementing new ways of working where opportunities emerge to leverage artificial intelligence tools to drive efficiency and reduce burden - Up to PS631,080 4. Extending specific service coverage to include privately funded care - Up to PS360,000 5. Additions or enhancements to the service delivery of the project - Up to PS1,200,000 6. Additional quality improvement initiatives either related to or linked with the project - Up to PS360,000 7. Inclusion of additional national or international funders (please refer to table 2 of section 13.4.1 of Annex A - Service Specification) - Up to PS1,817,926 8. Changes in line with national policy - Up to PS1,200,000" }, "language": "en" }